ClosedResearchRound 2
Emerging Industry Infrastructure Fund (EIIF) — NSW
Up to $6M available
Office of the Chief Scientist and Engineer
The Emerging Industry Infrastructure Fund (EIIF) Round 2 provided up to $6 million to support synthetic biology and biomanufacturing infrastructure, facilities, equipment and platforms in New South Wales. Funding targeted openly accessible research and innovation infrastructure that supports prototyping, scale-up, testing, collaboration and commercialisation.
Funding
Up to $6M
Closed
20 Oct 2022
Duration
Four years
Location
New South Wales
Who Can Apply
• Be a university or publicly funded research organisation (PFRO), their collaborative entities, a New South Wales-located NCRIS or other openly accessible research facility, a private firm operating openly accessible R&D and innovation infrastructure, or an eligible consortium.
• Have an Australian Business Number (ABN).
• Single-entity applicants must be headquartered in New South Wales and/or have a major research or innovation presence in New South Wales.
• For consortium applications, the proposal lead must be headquartered in New South Wales.
• Major presence means retaining 40 per cent or more of researchers, developers or other innovation staff in New South Wales for the agreement period.
• Be financially viable and likely to remain so over the duration of the project.
• Have the demonstrated skills and capacity to deliver the project.
• Ineligible applicants include consortia or partnerships with businesses that are insolvent.
• All grant monies must be used on activities undertaken within New South Wales and on staff, students or equipment to be located in New South Wales.
• Proposals spending grant funding on partners, activities or items outside New South Wales are ineligible, except for equipment purchased to bring into New South Wales.
• Projects must align to the New South Wales 20-Year R&D Roadmap and the state's needs in synthetic biology, biomanufacturing and genetic engineering.
Eligible applicants include universities or publicly funded research organisations (PFROs) or their collaborative entities; NSW-located National Collaborative Research Infrastructure Strategy (NCRIS) facilities or other openly accessible research facilities; private firms operating openly accessible R&D and innovation infrastructure; or consortium-based applications including industry organisations or firms, universities and PFROs, public sector organisations or other organisations. Single-entity applicants must be headquartered in New South Wales and/or have a major research or innovation presence in New South Wales. For consortium applications, the proposal lead must be headquartered in New South Wales. Applicants must have an Australian Business Number, be financially viable, demonstrate the skills and capacity to deliver the project, and use grant funds on activities undertaken within New South Wales and on staff, students or equipment located in New South Wales, except equipment purchased elsewhere to bring into New South Wales. Ineligible applicants include consortia or partnerships with insolvent businesses. Projects must align to the state's industry, technology and innovation needs for synthetic biology, biomanufacturing and genetic engineering identified in the NSW 20-Year R&D Roadmap.
What's Funded
Funding may support shared facilities, communal spaces, equipment and research infrastructure; pilot and demonstration-scale synthetic biology or biomanufacturing facilities; laboratory improvements for industry access; major equipment upgrades or replacement; technical experts; access to bioreactors and precision fermentation capability; business development or industry application staff; collaborative incubation and acceleration programs; and upskilling and professional development programs.Before you apply
Check Emerging Industry Infrastructure Fund (EIIF) fit and evidence gaps before 20 Oct 2022
Use this research grant page to sanity-check eligibility, funding fit, evidence gaps and application effort before you commit days to drafting. If you already know the grant you want, the 48-hour audit gives a practical go/no-go view, reviewer-readiness score and next-step risks.
Get a 48-hour grant fit auditExpected Outcomes
Expected outcomes include increased utilisation of infrastructure, stronger research-industry connections, improved prototyping, testing and scale-up capability, enhanced commercialisation pathways, open access for researchers and industry, and broader innovation ecosystem and skills impacts in New South Wales.Grant not accepting applications
Applications for this round are closed. A new round may open in the future.
Browse open grantsKey Information
Applicant Types
universitycompanyother
Stage
any
Funding Purposes
researchinnovationcommercialisationtrainingcapital_expenditureother
Keywords
synthetic biologybiomanufacturingresearch infrastructureinnovation infrastructurecommercialisationprototypingscale-uptesting
Frequently Asked Questions
1
What is the Emerging Industry Infrastructure Fund (EIIF)?
The Emerging Industry Infrastructure Fund (EIIF) is a research grant offered by Office of the Chief Scientist and Engineer in Australia, providing Up to $6M in funding. The Emerging Industry Infrastructure Fund (EIIF) Round 2 provided up to $6 million to support synthetic biology and biomanufacturing infrastructure, facilities, equipment and platforms in New South Wales. Funding targeted openly accessible research and innovation infrastructure that supports prototyping, scale-up, testing, collaboration and commercialisation.
2
How much funding does the Emerging Industry Infrastructure Fund (EIIF) provide?
The Emerging Industry Infrastructure Fund (EIIF) provides Up to $6M in funding. The typical project duration is Four years.
3
Who is eligible for the Emerging Industry Infrastructure Fund (EIIF)?
- Be a university or publicly funded research organisation (PFRO), their collaborative entities, a New South Wales-located NCRIS or other openly accessible research facility, a private firm operating openly accessible R&D and innovation infrastructure, or an eligible consortium.
- Have an Australian Business Number (ABN).
- Single-entity applicants must be headquartered in New South Wales and/or have a major research or innovation presence in New South Wales.
- For consortium applications, the proposal lead must be headquartered in New South Wales.
- Major presence means retaining 40 per cent or more of researchers, developers or other innovation staff in New South Wales for the agreement period.
- Be financially viable and likely to remain so over the duration of the project.
- Have the demonstrated skills and capacity to deliver the project.
- Ineligible applicants include consortia or partnerships with businesses that are insolvent.
- All grant monies must be used on activities undertaken within New South Wales and on staff, students or equipment to be located in New South Wales.
- Proposals spending grant funding on partners, activities or items outside New South Wales are ineligible, except for equipment purchased to bring into New South Wales.
- Projects must align to the New South Wales 20-Year R&D Roadmap and the state's needs in synthetic biology, biomanufacturing and genetic engineering.
4
When does the Emerging Industry Infrastructure Fund (EIIF) close?
Applications closed on 20 Oct 2022.
5
What activities are funded?
Funding may support shared facilities, communal spaces, equipment and research infrastructure; pilot and demonstration-scale synthetic biology or biomanufacturing facilities; laboratory improvements for industry access; major equipment upgrades or replacement; technical experts; access to bioreactors and precision fermentation capability; business development or industry application staff; collaborative incubation and acceleration programs; and upskilling and professional development programs.
6
How do I apply for the Emerging Industry Infrastructure Fund (EIIF)?
Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.
Need help applying?
Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.